Overview
Omphalocele, also known as exomphalos, is a congenital abdominal wall defect present at birth in which abdominal organs (such as the intestines, liver, or other viscera) herniate through the base of the umbilical cord and are covered by a membranous sac composed of peritoneum, Wharton's jelly, and amnion. The defect occurs during embryonic development when the abdominal contents fail to return to the abdominal cavity after their normal physiological herniation into the umbilical cord during the first trimester. Omphaloceles vary in size from small (containing only a few loops of bowel) to giant (containing the liver and other organs), and the size significantly influences clinical management and prognosis. Omphalocele primarily affects the abdominal wall and gastrointestinal system, but it is frequently associated with other congenital anomalies. Approximately 50–70% of affected infants have additional malformations, including congenital heart defects, genitourinary anomalies, musculoskeletal abnormalities, and chromosomal abnormalities such as trisomy 13, trisomy 18, and trisomy 21. Omphalocele is also a feature of recognized syndromes, including Beckwith-Wiedemann syndrome, pentalogy of Cantrell, and the omphalocele-exstrophy-imperforate anus-spinal defects (OEIS) complex. Pulmonary hypoplasia may occur, particularly in cases of giant omphalocele, due to reduced abdominal domain and impaired diaphragmatic development. Diagnosis is typically made prenatally via ultrasound, often during the second trimester. Postnatal management depends on the size of the defect and the presence of associated anomalies. Small omphaloceles may be repaired with primary surgical closure shortly after birth, while giant omphaloceles often require a staged approach, including the application of topical agents (such as silver sulfadiazine or povidone-iodine) to promote gradual epithelialization of the sac (the "paint and wait" technique), followed by delayed surgical repair. Supportive care including respiratory support, nutritional management, and treatment of associated anomalies is essential. Long-term outcomes are generally favorable for isolated omphalocele, but prognosis is significantly influenced by the presence and severity of associated anomalies and chromosomal abnormalities.
Clinical phenotype terms— hover any for plain English:
Multifactorial
Caused by a mix of several genes and environmental factors
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Omphalocele.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Omphalocele at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Omphalocele.
Community
No community posts yet. Be the first to share your experience with Omphalocele.
Start the conversation →Latest news about Omphalocele
No recent news articles for Omphalocele.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Omphalocele
What is Omphalocele?
Omphalocele, also known as exomphalos, is a congenital abdominal wall defect present at birth in which abdominal organs (such as the intestines, liver, or other viscera) herniate through the base of the umbilical cord and are covered by a membranous sac composed of peritoneum, Wharton's jelly, and amnion. The defect occurs during embryonic development when the abdominal contents fail to return to the abdominal cavity after their normal physiological herniation into the umbilical cord during the first trimester. Omphaloceles vary in size from small (containing only a few loops of bowel) to gian
How is Omphalocele inherited?
Omphalocele follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Omphalocele typically begin?
Typical onset of Omphalocele is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Omphalocele?
4 specialists and care centers treating Omphalocele are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.